Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Melatonin ameliorates anxiety and depression‐like behaviors and modulates proteomic changes in triple transgenic mice of Alzheimer's disease
Lulin Nie, Gang Wei, Shengming Peng, et al.
BioFactors (2017) Vol. 43, Iss. 4, pp. 593-611
Closed Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Melatonin prevents neuroinflammation and relieves depression by attenuating autophagy impairment through FOXO3a regulation
Tahir Ali, Shafiq Ur Rahman, Derek Hao, et al.
Journal of Pineal Research (2020) Vol. 69, Iss. 2
Closed Access | Times Cited: 268
Pineal Calcification, Melatonin Production, Aging, Associated Health Consequences and Rejuvenation of the Pineal Gland
Dun Tan, Bing Xu, Xinjia Zhou, et al.
Molecules (2018) Vol. 23, Iss. 2, pp. 301-301
Open Access | Times Cited: 178
Melatonin: Clinical Perspectives in Neurodegeneration
Daniel P. Cardinali
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 166
Role of melatonin in Alzheimer’s disease: From preclinical studies to novel melatonin-based therapies
Jaydeep Roy, K. Y. Wong, Luca Aquili, et al.
Frontiers in Neuroendocrinology (2022) Vol. 65, pp. 100986-100986
Closed Access | Times Cited: 47
Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
Azade Shabani, Fatemeh Foroozanfard, Elham Kavossian, et al.
Journal of Affective Disorders (2019) Vol. 250, pp. 51-56
Closed Access | Times Cited: 75
Melatonin induces mechanisms of brain resilience against neurodegeneration
Rubén Corpas, Christian Griñán‐Ferré, Verónica Palomera‐Ávalos, et al.
Journal of Pineal Research (2018) Vol. 65, Iss. 4
Closed Access | Times Cited: 73
Endogenous Melatonin Levels and Therapeutic Use of Exogenous Melatonin in Migraine: Systematic Review and Meta‐Analysis
Ioannis Liampas, Vasileios Siokas, Alexandros G. Brotis, et al.
Headache The Journal of Head and Face Pain (2020) Vol. 60, Iss. 7, pp. 1273-1299
Closed Access | Times Cited: 58
Neuroprotection: Targeting Multiple Pathways by Naturally Occurring Phytochemicals
Andleeb Khan, Sadaf Jahan, Zuha Imtiyaz, et al.
Biomedicines (2020) Vol. 8, Iss. 8, pp. 284-284
Open Access | Times Cited: 58
Therapeutic potential of glutathione-enhancers in stress-related psychopathologies
Ioannis Zalachoras, Fiona Hollis, Eva Ramos‐Fernández, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 114, pp. 134-155
Open Access | Times Cited: 54
Exploring the multifunctional role of melatonin in regulating autophagy and sleep to mitigate Alzheimer’s disease neuropathology
Md. Farhad Hossain, Ni Wang, Ruijun Chen, et al.
Ageing Research Reviews (2021) Vol. 67, pp. 101304-101304
Closed Access | Times Cited: 46
S-Glutathionylation and S-Nitrosylation in Mitochondria: Focus on Homeostasis and Neurodegenerative Diseases
Sofia Vrettou, Brunhilde Wirth
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15849-15849
Open Access | Times Cited: 30
Effectiveness and mechanisms of combined use of antioxidant nutrients in protecting against oxidative stress‐induced neuronal loss and related neurological deficits
Lu Wang, Yingjuan Wei, Zhenzhou Sun, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 8
Melatonin as an endogenous regulator of diseases: The role of autophagy
Ali Roohbakhsh, Ali Shamsizadeh, A. Wallace Hayes, et al.
Pharmacological Research (2018) Vol. 133, pp. 265-276
Closed Access | Times Cited: 56
Neuroprotective effect of melatonin against lipopolysaccharide-induced depressive-like behavior in mice
E.H. Taniguti, Y.S. Ferreira, I.J.V. Stupp, et al.
Physiology & Behavior (2018) Vol. 188, pp. 270-275
Closed Access | Times Cited: 54
Sex differences in adult zebrafish anxiolytic-like responses to diazepam and melatonin
Rafael Genário, Ana C.V.V. Giacomini, Murilo S. de Abreu, et al.
Neuroscience Letters (2019) Vol. 714, pp. 134548-134548
Closed Access | Times Cited: 54
Melatonin and Comorbidities in Children with Autism Spectrum Disorder
Katia Gagnon, Roger Godbout
Current Developmental Disorders Reports (2018) Vol. 5, Iss. 3, pp. 197-206
Open Access | Times Cited: 48
Loss of SST and PV positive interneurons in the ventral hippocampus results in anxiety-like behavior in 5xFAD mice
Hongzhu Li, Jiaying Zhao, Lanfeng Lai, et al.
Neurobiology of Aging (2022) Vol. 117, pp. 165-178
Closed Access | Times Cited: 26
Melatonin: a ferroptosis inhibitor with potential therapeutic efficacy for the post-COVID-19 trajectory of accelerated brain aging and neurodegeneration
Asmaa Yehia, Osama A. Abulseoud
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 6
Brain Inflammation Connects Cognitive and Non-Cognitive Symptoms in Alzheimer’s Disease
María Clara Sellés, Maurício M. Oliveira, Sérgio T. Ferreira
Journal of Alzheimer s Disease (2018) Vol. 64, Iss. s1, pp. S313-S327
Closed Access | Times Cited: 43
Effects of the Novel IDO Inhibitor DWG-1036 on the Behavior of Male and Female 3xTg-AD Mice
Emre Fertan, Kurt R. Stover, Michael G. Brant, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 41
Acrolein, an endogenous aldehyde induces Alzheimer's disease-like pathologies in mice: A new sporadic AD animal model
Chen Chen, Junfeng Lu, Weijia Peng, et al.
Pharmacological Research (2021) Vol. 175, pp. 106003-106003
Closed Access | Times Cited: 28
Investigation of Anxiety- and Depressive-like Symptoms in 4- and 8-Month-Old Male Triple Transgenic Mouse Models of Alzheimer’s Disease
Dorottya Várkonyi, Bibiána Török, Eszter Sipos, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10816-10816
Open Access | Times Cited: 22
Imbalance of multiple neurotransmitter pathways leading to depression-like behavior and cognitive dysfunction in the triple transgenic mouse model of Alzheimer disease
Meng Zhang, Liyuan Liu, Yong Xu, et al.
Metabolic Brain Disease (2023) Vol. 38, Iss. 7, pp. 2465-2476
Open Access | Times Cited: 13
Administering crocin ameliorates anxiety‐like behaviours and reduces the inflammatory response in amyloid‐beta induced neurotoxicity in rat
Mohammadmehdi Hadipour, Zahra Bahari, Mohammad Reza Afarinesh, et al.
Clinical and Experimental Pharmacology and Physiology (2021) Vol. 48, Iss. 6, pp. 877-889
Closed Access | Times Cited: 25
Night shift hormone: How does melatonin affect depression?
Gita Kholghi, Maliheh Eskandari, Mohammad-Saleh Shokouhi Qare Saadlou, et al.
Physiology & Behavior (2022) Vol. 252, pp. 113835-113835
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top